WA inhibits cancer metastasis by partially reversing the epithelial-to-mesenchymal pathway, targeting the urokinase-type plasminogen activator (uPA) and activating the transcription factors Notch2 and Notch4 and reducing Notch1 [39,41,43]. This evidence concerns the gene PLAU and cancer.